Literature DB >> 3046852

Multifrequency rhythms of immunological functions.

F Carandente1, A Angeli, A De Vecchi, F Dammacco, F Halberg.   

Abstract

Chrono-immunological functions are reviewed starting from the first studies on circadian variations in the count of circulating blood eosinophils to the most recent studies on lymphocyte subpopulation periodicities. Serum Ig levels, complement components, plaque forming cells, phagocytosis, autologous mixed lymphocyte reactions, have also been demonstrated to be circadian periodic. Transplant immunology is also known to show circadian and circa septan periodicities in the rejection of transplanted organs. Rhythms of susceptibility to a series of allergens and bronchial asthma symptoms characterize chronobiology in allergy. A periodic pattern is a common finding in the recurrence of the symptoms in rheumatoid arthritis. Finally, the beginnings of chrono-immunotherapy of experimental and human tumors are briefly reviewed. The conclusion that can be drawn from this short overview is that the demonstration of the periodicity in such a big number of variables in health and the modifications of the relevant parameters in disease, emphasize the importance of the predictable, since periodic, part of the variations that can be shown by the immunological findings.

Entities:  

Mesh:

Year:  1988        PMID: 3046852

Source DB:  PubMed          Journal:  Chronobiologia        ISSN: 0390-0037


  3 in total

Review 1.  Season of birth and risk for adult onset glioma.

Authors:  Jimmy T Efird
Journal:  Int J Environ Res Public Health       Date:  2010-04-28       Impact factor: 3.390

2.  Sleep-dependent activity of T cells and regulatory T cells.

Authors:  T Bollinger; A Bollinger; L Skrum; S Dimitrov; T Lange; W Solbach
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

3.  Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study.

Authors:  Patrick Brossard; Hartmut Derendorf; Jian Xu; Haidar Maatouk; Atef Halabi; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.